Medical News

RSS

Inefficiencies in treatment of chronic pain increases healthcare costs and prolongs patient suffering

A new report launched today in the European Parliament shows inefficiencies in the treatment of chronic pain result in increasing healthcare costs and prolonged patient suffering.

29 Sep 2010

Malaria vaccine development meeting begins in Washington

Agence France-Presse reports on a malaria vaccine development meeting that kicks off Tuesday in Washington, D.C.One of the stars at the meeting will be the RTS,S malaria vaccine, which has been developed by GlaxoSmithKline and the PATH Malaria Vaccine Initiative, with funding from the Bill & Melinda Gates Foundation, the news service writes.

29 Sep 2010

CAP cells produce high virus titers upon influenza strain infection

CEVEC Pharmaceuticals, the developer of an extremely potent protein expression system based on human CAP cells, announced today that CAP cells produce high virus titers upon infection with influenza strains. The virus titers are as good as or even higher than with MDCK and Vero cells, host cells currently used for influenza vaccine production.

29 Sep 2010

Children younger than 5 years account for over half of bathtub- and shower-related injuries

Bathtubs and showers are frequently associated with injuries to children. Although interventions have been initiated to prevent injuries due to submersions and hot water scalds, little attention has been paid to slips, trips and falls, which account for more than 80 percent of bathtub- and shower-related injuries.

29 Sep 2010

Crescendo Biologics successfully delivers triple knockout mice

Crescendo Biologics Limited today announces it has established a colony of engineered mice completely devoid of endogenous antibody polypeptides. The proprietary 'triple knockout' mice are believed to be unique and have the immunoglobulin heavy chain (IgH), kappa light chain and lambda light chain loci all functionally silenced by large-scale genomic deletion.

29 Sep 2010

BAC completes feasibility study on CaptureSelect affinity ligands for Genmab

BAC BV, the leading provider of antibody-based affinity purification technology, today announced that it successfully completed a feasibility study in its collaboration with Genmab A/S (Copenhagen, Denmark), an international biotechnology company developing human antibody therapeutics for the potential treatment of cancer.

29 Sep 2010

Scientists develop NIA assay to determine drug's differential effects in tumor cells

A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.We are making progress toward the goal of understanding how drugs work in different individuals, said Alice C. Fan, M.D., instructor in the division of oncology at Stanford University School of Medicine.

29 Sep 2010

Study analyses CT for screening of coronary artery calcification in radiation-induced cancer cases

A study based on computer modeling of radiation risk suggests that widespread screening for the buildup of calcium in the arteries using computed tomography scans would lead to an estimated 42 additional radiation-induced cancer cases per 100,000 men and 62 cases per 100,000 women, according to a report in the July 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

29 Sep 2010

HIV care providers call Senate leaders to support Pennsylvania Legislation on HIV testing

HIV care providers from across the state today called upon key Senate leaders to support pending legislation that would change the current Pennsylvania law on HIV testing by removing the requirement for written informed consent and pre-test counseling.

29 Sep 2010

Canadians living with depression significantly underestimate others' perceptions about illness

A new national survey reveals a vast gap between how Canadians living with depression view their condition, compared to how it is viewed in reality by the general population, possibly preventing them from seeking the best treatment and care. Most Canadians with depression feel their illness is not perceived by the public as a medical condition or a serious illness (81 per cent) when in fact less than five per cent of the general population actually has that view. In fact, the majority of Canadians (72 per cent) recognize depression as both serious and treatable.

29 Sep 2010

ECOWAS forum highlights need for nutrition to be integrated with agriculture

A recent nutrition forum, held by the Economic Community of West African States (ECOWAS), looked at how to better incorporate nutrition into agriculture, IRIN reports.

29 Sep 2010

Morphotek announces first therapeutic monoclonal antibody for clinical development

Morphotek, Inc., a subsidiary of Eisai Inc., today announced that a monoclonal antibody has been selected for advancement to clinical development under the terms of its March 2009 collaboration agreement with Human Genome Sciences, Inc.

29 Sep 2010

Chemical contaminants interact with noise and modify manifestation of work-related 'deafness'

A study carried out by Spanish researchers has shown that the presence of chemical contaminants can interact with noise and modify, for good or for bad, the way in which work-related "deafness" - which is increasingly common among young people - manifests itself. Noise-related hearing loss is the most common occupational disease in Europe.

29 Sep 2010

Study finds naturally-derived trehalose inhibits fat cell hypertrophy

Hayashibara Biochemical Laboratories, Inc. based in Okayama City, Okayama Prefecture, Japan, has confirmed that the naturally-derived functional saccharide trehalose has the effect of inhibiting fat cell hypertrophy.

29 Sep 2010

Online games boost brainpower and prevent memory loss associated with age

Recent studies done by the psychology department at the University of Illinois, have confirmed what online casinos have been saying for some time; playing online games can boost a person's brainpower and prevent memory loss that comes with age.

29 Sep 2010

Some Democrats, including Reid, embrace health law as fall campaign battles continue

Politico: Some House Democrats are touting the new health law — and their support of it — as a positive in their fights to keep their seats in midterm elections this fall. The Democrats are "framing key provisions as a 'Patient's Bill of Rights.' Spurred by last week's release of a series of rigid insurance rules, the lawmakers are defying this election season's conventional wisdom placing by health care front and center." Among them are Reps. Dina Titus and Shelley Berkley or Nevada.

29 Sep 2010

Emergency treatment of anaphylaxis with epinephrine by trained non-medical professionals endorsed

The Epinephrine Roundtable was convened during the 25th Annual Meeting of the Wilderness Medical Society (WMS) in 2008 to explore areas of consensus and uncertainty in the field treatment of anaphylaxis. The panel endorsed the administration of epinephrine to treat anaphylaxis in the field under emergency conditions by trained non-medical professionals. Anaphylaxis, an acute allergic reaction, is sudden in onset and requires immediate treatment. The recommendations of the panel are published in the September issue of Wilderness & Environmental Health.

29 Sep 2010

New topical microbicide gel can prevent HIV transmission

Amyloid protein structures are best known for the troubles they pose in the brains of Alzheimer's patients. Now researchers are trying to exploit their presence in a very different place in semen to find a new way to stop HIV.

29 Sep 2010

Study finds PEM scanners equivalent to breast MRI in detecting cancerous lesions

In a prospective study published in the European Journal of Nuclear Medicine and Molecular Imaging, researchers at Boca Raton Regional Hospital (Boca Raton, FL) showed that Positron Emission Mammography (PEM) and breast MRI had comparably high ability to detect cancerous lesions.

29 Sep 2010

Synosia's SYN-118 HPPD inhibitor beneficial for Parkinson's patients: Study

Synosia Therapeutics today announced the first clinical study results showing that SYN-118 provides clinically meaningful benefits to Parkinson's patients, has a good safety profile and is well tolerated. Results from an open-label, proof-of-mechanism study of SYN-118 (CL02) were presented at the World Parkinson Congress in Glasgow, Scotland.

29 Sep 2010

Medical News

Inefficiencies in treatment of chronic pain increases healthcare costs and prolongs patient suffering

Malaria vaccine development meeting begins in Washington

CAP cells produce high virus titers upon influenza strain infection

Children younger than 5 years account for over half of bathtub- and shower-related injuries

Crescendo Biologics successfully delivers triple knockout mice

BAC completes feasibility study on CaptureSelect affinity ligands for Genmab

Scientists develop NIA assay to determine drug's differential effects in tumor cells

Study analyses CT for screening of coronary artery calcification in radiation-induced cancer cases

HIV care providers call Senate leaders to support Pennsylvania Legislation on HIV testing

Canadians living with depression significantly underestimate others' perceptions about illness

ECOWAS forum highlights need for nutrition to be integrated with agriculture

Morphotek announces first therapeutic monoclonal antibody for clinical development

Chemical contaminants interact with noise and modify manifestation of work-related 'deafness'

Study finds naturally-derived trehalose inhibits fat cell hypertrophy

Online games boost brainpower and prevent memory loss associated with age

Some Democrats, including Reid, embrace health law as fall campaign battles continue

Emergency treatment of anaphylaxis with epinephrine by trained non-medical professionals endorsed

New topical microbicide gel can prevent HIV transmission

Study finds PEM scanners equivalent to breast MRI in detecting cancerous lesions

Synosia's SYN-118 HPPD inhibitor beneficial for Parkinson's patients: Study

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News